307
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Receptor-based QSAR study for a series of 3,3-disubstituted-5-aryl oxindoles and 6-aryl benzimidazol-2-ones derivatives as progesterone receptor inhibitors

, , , , , & show all
Pages 775-799 | Received 29 Mar 2011, Accepted 09 Sep 2011, Published online: 17 Oct 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

V. K. Vyas, H. G. Bhatt, P. K. Patel, J. Jalu, C. Chintha, N. Gupta & M. Ghate. (2013) CoMFA and CoMSIA studies on C-aryl glucoside SGLT2 inhibitors as potential anti-diabetic agents. SAR and QSAR in Environmental Research 24:7, pages 519-551.
Read now

Articles from other publishers (4)

Asmaa Saber, El Hassane Anouar, Ghizlane Sebbar, Brahim El Ibrahimi, Mohamed Srhir, Tuncer Hökelek, Joel T. Mague, Lhoussaine El Ghayati, Nada Kheira Sebbar & El Mokhtar Essassi. (2021) New 1,2,3-triazole containing benzimidazolone derivatives: Syntheses, crystal structures, spectroscopic characterizations, Hirshfeld surface analyses, DFT calculations, anti-corrosion property anticipation, and antibacterial activities. Journal of Molecular Structure 1242, pages 130719.
Crossref
Udit Chaube & Hardik Bhatt. (2017) 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors. Molecular Diversity 21:3, pages 741-759.
Crossref
Vakhid A. Mamedov, Nataliya A. Zhukova & Oleg G. Sinyashin. (2017) Advances in the synthesis of benzimidazolones via rearrangements of benzodiazepinones and quinoxalin(on)es. Mendeleev Communications 27:1, pages 1-11.
Crossref
Vakhid A. Mamedov & Nataliya A. Zhukova. 2017. 1 43 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.